In the entrepreneurial space, “cool” really has nothing to do with physical features. It is more of a state of mind and community. Think Austin, Texas, or Portland, Ore., or San Francisco.
From The Oklahoman: i2E Inc. recently closed on a $1.75 million Series A equity investment in Oklahoma City-based WeGoLook LLC.
i2E, Inc., recently closed on a $1.75 million Series A equity investment in Oklahoma City-based WeGoLook, LLC, which provides onsite verification services through a national network of 15,000 field agents.
The State Science & Technology Institute, the national organization focused on improving state economies through science, technology, and innovation, recently chose Oklahoma as the site for the 2015 annual SSTI Conference.
We’d better accept that the education of Oklahoma’s young people is the business of business, and invite input from the business community on the appropriate standards of education.
The Dean McGee Eye Institute offers Dr. Dimitrios Karamichos, a rising star at Harvard Medical School, an offer he can’t refuse to relocate to Oklahoma.
Three-fourths of the companies responding to our 2014 client survey said that access to capital is their most critical issue. They also tell us that’s why many of them first make contact with i2E.
Oklahoma City has been selected to host the 2015 State Science & Technology Institute (SSTI) Conference. The event will be held October 26-28 at the Cox Convention Center.
It is with great sadness that we share with you that longtime i2E board member, Bob Craine passed away.
SeedStep Angels network was founded in 2009 and began making investments in 2010, and i2E manages the group.
For technology developed at the University of Oklahoma, the first stop on the road to market is the Office of Technology Development.
Oklahoma City-based Caisson Biotech sponsored a recent high school scientific project that was out of this world.
Anyone who knows me knows that STEM (science, technology, engineering, and math) education is one of my hot buttons.
Synereca Pharmaceuticals has received $1.4 million in seed capital from i2E Inc. The Oklahoma City-based company is developing a compound that kills drug resistant bacteria.